Drug Trial Radar · NCT02724228
A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
Last checked: Nov 20, 2026Latest source record: Mar 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
30
Actual
Start
Jan 26, 2016
Primary completion
Dec 2027
Study completion Feb 2028
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Mar 31, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 7 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of BMN 111 in Children with Achondroplasia. The primary objective is to evaluate the long-term safety and tolerability of daily SC injections of BMN 111 in children with ACH who have completed two years of treatment in the 111-202 study.
Conditions
- Achondroplasia
Interventions
BMN 111Drug
BMN 111 will be administered subcutaneously daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]Time frame: Until near final adult height is reached, and up to at least 16 years of age for females and 18 years of age for males, whichever occurs later
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
Children's Hospital & Research Center Oakland
Oakland, California
Harbor - UCLA Medical Center
Torrance, California
Ann and Robert H. Lurie Childrens Hospital of Chicago
Chicago, Illinois
Johns Hopkins McKusick - Institute of Genetic Medicine
Baltimore, Maryland
Vanderbilt University
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
Murdoch Children's Research Institute
Parkville, Victoria, Australia
Institut Necker
Paris, France
Guys & St. Thomas NHS Foundation Trust Evelina Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.